| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |